DE3462896D1 - Novel calcitonin and collection thereof - Google Patents

Novel calcitonin and collection thereof

Info

Publication number
DE3462896D1
DE3462896D1 DE8484114768T DE3462896T DE3462896D1 DE 3462896 D1 DE3462896 D1 DE 3462896D1 DE 8484114768 T DE8484114768 T DE 8484114768T DE 3462896 T DE3462896 T DE 3462896T DE 3462896 D1 DE3462896 D1 DE 3462896D1
Authority
DE
Germany
Prior art keywords
collection
novel calcitonin
calcitonin
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8484114768T
Other languages
German (de)
English (en)
Inventor
Hisayuki Matsuo
Kenji Kangawa
Sachio C O Central Rese Hirose
Motoo C O Central Res Watanabe
Tamotsu C O Central Rese Homma
Hidenari Adachi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Chemical Corp
Original Assignee
Mitsubishi Yuka Pharmaceutical Co Ltd
Mitsubishi Petrochemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Yuka Pharmaceutical Co Ltd, Mitsubishi Petrochemical Co Ltd filed Critical Mitsubishi Yuka Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE3462896D1 publication Critical patent/DE3462896D1/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/585—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DE8484114768T 1983-12-08 1984-12-05 Novel calcitonin and collection thereof Expired DE3462896D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58230593A JPS60123500A (ja) 1983-12-08 1983-12-08 新規カルシトニン及びその採取法

Publications (1)

Publication Number Publication Date
DE3462896D1 true DE3462896D1 (en) 1987-05-07

Family

ID=16910165

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8484114768T Expired DE3462896D1 (en) 1983-12-08 1984-12-05 Novel calcitonin and collection thereof

Country Status (3)

Country Link
EP (1) EP0146842B1 (OSRAM)
JP (1) JPS60123500A (OSRAM)
DE (1) DE3462896D1 (OSRAM)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0678357B2 (ja) * 1984-08-29 1994-10-05 三菱油化株式会社 新規ペプチド
EP0252097A1 (en) * 1985-12-19 1988-01-13 MOLONEY, Thomas J. A draw-case
FR2592049B1 (fr) * 1985-12-24 1988-02-12 Milhaud Gerard Nouveaux analogues de composes polypeptidiques hypocalcemiants epargnant le calcium de l'organisme, leur preparation et les medicaments contenant ces principes actifs
ES2097806T3 (es) * 1990-03-30 1997-04-16 Shiseido Co Ltd Procedimiento para purificar un polipeptido.
KR960031478A (ko) * 1995-02-14 1996-09-17 성재갑 유비퀴틴 융합 인간 칼시토닌의 정제방법
NL1002400C2 (nl) * 1996-02-20 1997-08-21 Friesland Brands Bv Oraal calcitonine-preparaat en werkwijze voor het winnen van calcitonine.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3926938A (en) * 1974-08-12 1975-12-16 Armour Pharma Synthesis of salmon calcitonin

Also Published As

Publication number Publication date
JPS60123500A (ja) 1985-07-02
EP0146842B1 (en) 1987-04-01
JPH0339520B2 (OSRAM) 1991-06-14
EP0146842A1 (en) 1985-07-03

Similar Documents

Publication Publication Date Title
DE3278284D1 (en) Polyimide-esters and filaments
GB8525127D0 (en) Collection bag
DE3365292D1 (en) Pick and place unit
IL68100A0 (en) Novel dna and use thereof
GB2158233B (en) Improvements in dust collection
ZA857124B (en) 13-halomilbemycins and 13-hydroxymilbemycins
GB2224742B (en) Polyanhydride-siloxanes and polymide-siloxanes obtained therefrom
GB2142335B (en) Human calcitonin 2
ZA842202B (en) Phenylaminobenzenealkanols and preparation
DE3562486D1 (en) Arginyl-3-carboxy-4-hydroxyanilide and their use
DE3462896D1 (en) Novel calcitonin and collection thereof
DE3471652D1 (en) Diurethane-diureas and use
IL72755A0 (en) Novel pyrazolylsulfonylureas and isoxazolylsulfonylureas
GB2126230B (en) Substituted 1-pyridyloxy-3-indolylalkylamino-2-propanols preparation and use thereof
GB2136555B (en) Improvements in flares
GB8333223D0 (en) Umbrellas
JPS57158745A (en) Novel n-acyl-polypeptides and manufacture
GB8425511D0 (en) Powered sieve device
EP0134546A3 (en) Novel strains and use thereof
ZA832078B (en) Novel dna and use thereof
PH20880A (en) Substituted benzoxepines and isochromanes
DE3472250D1 (en) Novel halonitriles and their preparation
DE3463048D1 (en) Furan-3-hydroxamates and their use
GB2141121B (en) 1-phenoxy-3-hydroxyindolyl-alkylamino-3-propanols and preparation
DE3367919D1 (en) Furochromones and furobenzopyrans

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: MITSUBISHI PETROCHEMICAL CO., LTD. MITSUBISHI CHEM

8328 Change in the person/name/address of the agent

Free format text: EITLE, W., DIPL.-ING. HOFFMANN, K., DIPL.-ING. DR.RER.NAT. LEHN, W., DIPL.-ING. FUECHSLE, K., DIPL.-ING. HANSEN, B., DIPL.-CHEM. DR.RER.NAT. BRAUNS, H., DIPL.-CHEM. DR.RER.NAT. GOERG, K., DIPL.-ING. KOHLMANN, K., DIPL.-ING. KOLB, H., DIPL.-CHEM. DR.RER.NAT. RITTER UND EDLER VON FISCHERN, B., DIPL.-ING., PAT.-ANWAELTE NETTE, A., RECHTSANW., 8000 MUENCHEN

8327 Change in the person/name/address of the patent owner

Owner name: MITSUBISHI PETROCHEMICAL CO., LTD. MITSUBISHI KASE

8339 Ceased/non-payment of the annual fee